BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 17519122)

  • 1. Compliance and fixed-dose combination therapy.
    Bangalore S; Shahane A; Parkar S; Messerli FH
    Curr Hypertens Rep; 2007 Jun; 9(3):184-9. PubMed ID: 17519122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of hypertension with fixed dose combinations of candesartan cilexetil and hydrochlorothiazide: patient perspectives and clinical utility.
    Mengden T; Uen S; Bramlage P
    Vasc Health Risk Manag; 2009; 5():1043-58. PubMed ID: 20057897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fixed-dose combinations improve medication compliance: a meta-analysis.
    Bangalore S; Kamalakkannan G; Parkar S; Messerli FH
    Am J Med; 2007 Aug; 120(8):713-9. PubMed ID: 17679131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fixed-dose combination therapy in hypertension: cons.
    Angeli F; Reboldi G; Mazzotta G; Garofoli M; Ramundo E; Poltronieri C; Verdecchia P
    High Blood Press Cardiovasc Prev; 2012 Jun; 19(2):51-4. PubMed ID: 22867089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Real-life treatment patterns, compliance, persistence, and medication costs in patients with hypertension in Germany.
    Breitscheidel L; Ehlken B; Kostev K; Oberdiek MS; Sandberg A; Schmieder RE
    J Med Econ; 2012; 15(1):155-65. PubMed ID: 22035215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triple-combination therapy in the treatment of hypertension: a review of the evidence.
    Düsing R; Waeber B; Destro M; Santos Maia C; Brunel P
    J Hum Hypertens; 2017 Aug; 31(8):501-510. PubMed ID: 28230062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rationale for fixed-dose combinations in the treatment of hypertension: the cycle repeats.
    Sica DA
    Drugs; 2002; 62(3):443-62. PubMed ID: 11827559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of fixed-dose combination therapy in the treatment of patients with hypertension: focus on amlodipine/valsartan.
    da Silva PM
    Clin Drug Investig; 2010; 30(9):625-41. PubMed ID: 20626210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Issues in blood pressure control and the potential role of single-pill combination therapies.
    Burnier M; Brown RE; Ong SH; Keskinaslan A; Khan ZM
    Int J Clin Pract; 2009 May; 63(5):790-8. PubMed ID: 19220523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Fixed-dose combinations in the first line of antihypertensive therapy].
    Urbán L; Mészáros A
    Acta Pharm Hung; 2007; 77(3):180-4. PubMed ID: 18019783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Relationship of polymedication in controlling blood pressure: compliance, persistence, costs and incidence of new cardiovascular events].
    Sicras Mainar A; Muñoz Ortí G; Font Ramos B; Majós Oró N; Navarro Artieda R; Ibáñez Nolla J
    Med Clin (Barc); 2013 Jul; 141(2):53-61. PubMed ID: 22766057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rationale for triple fixed-dose combination therapy with an angiotensin II receptor blocker, a calcium channel blocker, and a thiazide diuretic.
    Volpe M; Tocci G
    Vasc Health Risk Manag; 2012; 8():371-80. PubMed ID: 22745561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compliance with antihypertensive therapy in the elderly: a comparison of fixed-dose combination amlodipine/benazepril versus component-based free-combination therapy.
    Dickson M; Plauschinat CA
    Am J Cardiovasc Drugs; 2008; 8(1):45-50. PubMed ID: 18303937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using fixed-dose combination therapies to achieve blood pressure goals.
    Chrysant SG
    Clin Drug Investig; 2008; 28(11):713-34. PubMed ID: 18840014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How do compliance, convenience, and tolerability affect blood pressure goal rates?
    Erdine S
    Am J Cardiovasc Drugs; 2012 Oct; 12(5):295-302. PubMed ID: 22920049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimizing the Management of Uncontrolled Hypertension: What do Triple Fixed-Dose Drug Combinations Add?
    Thomopoulos C; Katsimagklis G; Archontakis S; Skalis G; Makris T
    Curr Vasc Pharmacol; 2017; 16(1):61-65. PubMed ID: 28413969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical experience in treating hypertension with fixed-dose combination therapy: angiotensin II receptor blocker losartan plus hydrochlorothiazide.
    Abe M; Okada K; Matsumoto K
    Expert Opin Drug Metab Toxicol; 2009 Oct; 5(10):1285-303. PubMed ID: 19761411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Free versus Fixed Combination Antihypertensive Therapy for Essential Arterial Hypertension: A Systematic Review and Meta-Analysis.
    Mallat SG; Tanios BY; Itani HS; Lotfi T; Akl EA
    PLoS One; 2016; 11(8):e0161285. PubMed ID: 27548060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fixed-dose triple-combination treatments in the management of hypertension.
    Ram CV
    Manag Care; 2013 Dec; 22(12):45-55. PubMed ID: 24555265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
    Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
    J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.